Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-13, Stock:ABBV, The news for the past five days is as follows:
2019-11-06: NEWS1: AbbVie Announces Launch of Private Offering of Senior Unsecured Notes.NEWS2: Should You Worry About AbbVie Inc.'s (NYSE:ABBV) CEO Pay Cheque?.
2019-11-07: NEWS1: Zacks.com featured highlights include: Group 1 Automotive, AbbVie, Brinker International, Hewlett Packard Enterprise and Bristol-Myers Squibb.NEWS2: AbbVie Inc. -- Moody's assigns Baa2 to AbbVie's new sr. notes; stable outlook.
2019-11-08: NEWS1: Psst! Want the Secret to Picking Winning Stocks? Keep Reading..NEWS2: 10 Medical Marijuana Stocks to Cure Your Portfolio.NEWS3: AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA® (ibrutinib) in Combination with Rituximab for the Treatment of Previously Untreated, Younger Adults with Chronic Lymphocytic Leukemia.NEWS4: AbbVie Rises 3%.NEWS5: AbbVie Announces Results of Early Participation in Exchange Offers and Consent Solicitations for Allergan Notes.
2019-11-11: NEWS1: Top Research Reports for Toyota, Netflix & AbbVie.NEWS2: Mario Gabelli Continues to Buy AbbVie, Axalta.NEWS3: AbbVie Eyes Approval for Imbruvica+Rituxan in First-Line CLL.
2019-11-12: NEWS1: AbbVie Sells $30 Billion of Bonds to Fund Allergan Acquisition.NEWS2: US Indexes End the Day Higher Tuesday.NEWS3: Corporations Pile Into Bond Market as Borrowing Costs Drop.NEWS4: New Positive Data for RINVOQ™ (upadacitinib) on Signs and Symptoms in Patients with Ankylosing Spondylitis Presented at 2019 ACR/ARP Annual Meeting.NEWS5: The Zacks Analyst Blog Highlights: Toyota, Netflix, AbbVie, Gilead and Fiserv.NEWS6: AbbVie Rises 3%.NEWS7: AbbVie sells $30bn of bonds to finance Allergan takeover.NEWS8: AbbVie readies $30bn bond sale to finance Allergan takeover.NEWS9: AbbVie Eyes Up to $28 Billion Bond Sale to Finance Allergan Deal: Report.NEWS10: AbbVie readies $27bn bond sale to finance Allergan takeover.

Answer: Rise